Meilleure Health International Industry Group Ltd is an investment holding company mainly engaged in the production and sale of cannabis health products. The Company operates through four segments. The Healthcare-Related Business segment is engaged in health management services, medical beauty services, and sales of health-related products and Cannabidiol (CBD) downstream products. The Property-Related Business segment is engaged in real estate sales agency, investment property leasing, and residential property development and sales. The Trading Business segment is engaged in the trading of building materials and new energy products, the provision of new energy product procurement services, and health-related product sales agency services. The Equity Investment Business segment is engaged in the management of investment portfolio.

Employees

Sector

Pharmaceuticals

Calendar

07-31 - Ex-dividend date - 0.004 HKD

More about the company

Quotes

Date	Price	Change	Volume
26-07-14	HK$0.2500	0.00%	1,380,000
26-07-13	HK$0.2500	0.00%	0
26-07-10	HK$0.2500	0.00%	12,000
26-07-09	HK$0.2500	-3.85%	42,000
26-07-08	HK$0.2600	+4.00%	240,000

Delayed Quote Hong Kong S.E.

More quotes

Income Statement and Estimates

More financial data

Delayed Hong Kong S.E. Other stock markets 04:08:53 2026-07-14 EDT			5-day change	1st Jan Change
0.2500 ^HKD	0.00%		0.00%	-5.66%

07-07	Meilleure Health Forecasts Rise in H1 Profit	MT
06-26	Meilleure Health International Industry Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2025	CI

Market Cap	1.01B 129M 113M 104M 96.54M 182M 12.42B 185M 1.25B 489M 6.08B 486M 475M 20.95B	P/E 2024	36.7x	P/E 2025	28.5x
Enterprise Value	1.38B 176M 154M 142M 132M 248M 16.93B 252M 1.7B 666M 8.29B 662M 648M 28.55B	EV / Sales 2024	28.8x	EV / Sales 2025	39.6x
Free-Float	30.95%	Yield 2024	1.38%	Yield 2025	2.08%

07-07	Meilleure Health Forecasts Rise in H1 Profit	MT
06-26	Meilleure Health International Industry Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2025	CI
03-27	Meilleure Health International Industry Group Limited Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-27	Meilleure Health International Industry Group Limited Recommends Payment of Final Dividend for the Year Ended December 31, 2025, Payable on August 28, 2026	CI
01-08	Meilleure Health to Acquire Chinese Property Leasing Firm for HK$137 Million	MT
01-08	Meilleure Health International Industry to buy Jiangsu Yide for RMB124.8 million	RE
01-07	Meilleure Health International Industry Group Limited signed a Equity Interest Transfer Agreement to acquire Jiangsu Yide Investment Company Limited from Zhou Chuan and Tan Wensheng for approximately CNY 120 million.	CI
01-07	Meilleure Health International Industry Group Limited commences an Equity Buyback Plan for 409,375,663 shares, representing 10% of its issued share capital, under the authorization approved on June 27, 2025.	CI
12-31	Meilleure Health International Industry Group Limited Announces Company Secretary Changes, Effective December 31, 2025	CI
12-31	Meilleure Health International Industry Group Limited Announces Changes in Nomination Committee, Effective December 31, 2025	CI
25-08-28	Meilleure Health International Industry Group Limited Announces Interim Dividend for the Six Months Ended 30 June 2025, Payable on 31 October 2025	CI
25-08-28	Tranche Update on Meilleure Health International Industry Group Limited's Equity Buyback Plan announced on January 6, 2025.	CI
25-08-28	Meilleure Health International Industry Group Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI

21-04-22	Meilleure Health International Industry : GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; RE-ELECTION OF DIRECTORS; CLOSURE OF REGISTER OF MEMBERS; AND NOTICE OF ANNUAL GENERAL MEETING	PU
21-04-22	PROXY FORM FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 24 JUNE 2021 AT 11:00 A.M. AND ANY ADJOURNMENT THEREOF	PU
20-09-15	Meilleure Health International Industry : (1) REVISION OF ANNUAL CAP OF CONTINUING CONNECTED TRANSACTIONS FOR THE YEAR ENDING 31 DECEMBER 2020; AND (2) CONTINUING CONNECTED TRANSACTIONS IN RELATION TO RENEWAL OF FRAMEWORK AGREEMENT	PU
20-08-16	Meilleure Health International Industry : INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2020	PU
20-03-15	Meilleure Health International Industry : PROFIT WARNING	PU

Meilleure Health International Industry Group Limited Stock

Stocks

2327

BMG5975D1048

Pharmaceuticals

Valuation: Meilleure Health International Industry Group Limited

Chart: Meilleure Health International Industry Group Limited

Latest news : Meilleure Health International Industry Group Limited

Press Releases: Meilleure Health International Industry Group Limited

Quotes and Performance

Course Extremes

Managers and Directors: Meilleure Health International Industry Group Limited

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Income Statement and Estimates

Current month	-1.96%
1 month	-10.71%
3 months	-7.41%
6 months	-7.41%
Current year	-5.66%

1 week	0.25	0.27
1 month	0.24	0.27
Current year	0.21	0.3
1 year	0.21	0.31
3 years	0.11	0.32
5 years	0.11	0.48
10 years	0.11	1.64

Manager	Title	Age	Since
Wen Chuan Zhou CEO	Chief Executive Officer	43	2013-08-29
Kwai Kwan Tsoi SEC	Corporate Secretary	34	2025-12-30
Mei Yi Chu SEC	Corporate Secretary	33	2025-12-30

Director	Title	Age	Since
Xu Zhou Zhou CHM	Chairman	70	2013-08-29
Wen Chuan Zhou BRD	Director/Board Member	43	2013-08-29
Chi Wai Chau BRD	Director/Board Member	64	2013-08-29

Date	Insider	Type	Main position	Quantity	% Market Cap.
07-07	Wen Chuan Zhou	Other	Chief Executive Officer	240,000	0.0059%
06-11	Xu Zhou Zhou	Other	Chairman	900,000	0.0220%
05-13	Xu Zhou Zhou	Other	Chairman	2,400,000	0.0586%

	2024	2025
Net sales	50.68M 6.47M 5.65M 5.22M 4.83M 9.09M 621M 9.25M 62.29M 24.44M 304M 24.29M 23.75M 1.05B	36.52M 4.66M 4.07M 3.76M 3.48M 6.55M 448M 6.67M 44.89M 17.61M 219M 17.5M 17.11M 755M
Net income	32.48M 4.14M 3.62M 3.35M 3.09M 5.82M 398M 5.93M 39.92M 15.66M 195M 15.57M 15.22M 671M	37.98M 4.85M 4.24M 3.91M 3.62M 6.81M 465M 6.93M 46.69M 18.32M 228M 18.2M 17.8M 785M
Net Debt	273M 34.85M 30.45M 28.15M 26.01M 48.98M 3.35B 49.87M 336M 132M 1.64B 131M 128M 5.64B	368M 46.94M 41.02M 37.92M 35.03M 65.97M 4.51B 67.17M 452M 177M 2.21B 176M 172M 7.6B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MEILLEURE HEALTH INTERNATIONAL INDUSTRY GROUP LIMITED	0.00%	0.00%	-16.67%	-10.71%	129M
ELI LILLY AND COMPANY	-2.48%	-6.72%	+44.19%	+156.43%	1,028B
JOHNSON & JOHNSON	-1.52%	-5.01%	+61.87%	+58.79%	611B
ABBVIE INC.	-1.30%	-3.88%	+27.81%	+79.97%	432B
ROCHE HOLDING AG	-1.12%	-3.68%	+26.89%	+20.58%	323B
NOVARTIS AG	-1.73%	-3.45%	+26.95%	+44.09%	277B
ASTRAZENECA PLC	-1.95%	-13.92%	+15.96%	+19.76%	257B
NOVO NORDISK A/S	-1.45%	-2.37%	-27.87%	-39.87%	217B
AMGEN INC.	-1.44%	-3.49%	+19.60%	+56.20%	192B
GILEAD SCIENCES, INC.	-1.04%	-4.63%	+16.01%	+68.47%	161B
Average	-1.11%	-3.74%	+19.48%	+45.37%	349.85B
Weighted average by Cap.	-0.90%	-4.76%	+33.11%	+76.73%